| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/11/2013 | CA2849881A1 Pharmaceutical methods and topical compositions containing acitretin |
| 04/10/2013 | EP2578684A1 Antagonists of ligands and uses thereof |
| 04/10/2013 | EP2578236A1 PREPARATION OF MICROVESICLE-siRNA COMPLEXES AND USE THEREOF IN AIDS TREATMENT |
| 04/10/2013 | EP2578235A2 Liquid formulation of G-CSF conjugate |
| 04/10/2013 | EP2578234A1 Sugar responsive gel and medicine administering device |
| 04/10/2013 | EP2578211A1 6-decaprenyl-2,3-dimethoxy-5-methyl-1,4-benzoquinone-based composition and method for the production thereof |
| 04/10/2013 | EP2578209A1 Nanoparticulate composition containing antibiotics for intramammary administration in animals |
| 04/10/2013 | EP2578186A2 Drug-delivery endovascular stent and method for treating restenosis |
| 04/10/2013 | EP2576701A2 Preparation for use in ophthalmology and retinal surgery |
| 04/10/2013 | EP2576638A2 Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
| 04/10/2013 | EP2576595A1 Mitochondrial penetrating peptides as carriers for anticancer compounds |
| 04/10/2013 | EP2576594A1 Mitochondrial penetrating peptides as carriers for antimicrobials |
| 04/10/2013 | EP2576575A1 Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof |
| 04/10/2013 | EP2575908A1 Conjugated polymeric material and uses thereof |
| 04/10/2013 | EP2575893A1 Conjugates for the prevention or treatment of nicotine addiction |
| 04/10/2013 | EP2575892A1 2-iminobiotin formulations and uses thereof |
| 04/10/2013 | EP2575891A1 Formulations preserving bioactivity and methods of their preparation |
| 04/10/2013 | EP2575890A1 Antipsychotic injectable depot composition |
| 04/10/2013 | EP2575889A2 Stable pharmaceutical compositions of rapamycin esters |
| 04/10/2013 | EP2575888A2 Nasal immunization |
| 04/10/2013 | EP2575887A1 Optimized drug conjugates |
| 04/10/2013 | EP2575886A1 Nanocarrier compositions with uncoupled adjuvant |
| 04/10/2013 | EP2575876A1 Multivalent synthetic nanocarrier vaccines |
| 04/10/2013 | EP2575845A2 Aqueous formulations for coating microneedle arrays |
| 04/10/2013 | EP2575822A2 Topical pharmaceutical compositions comprising mometasone furoate |
| 04/10/2013 | EP2575820A1 Controlled release dosage form comprising quetiapine |
| 04/10/2013 | EP2575804A1 Methods of treatment of pancreatic cancer |
| 04/10/2013 | EP2575803A1 Methods of treating bladder cancer |
| 04/10/2013 | EP2575798A1 Gastroretentive dosage forms of gaba analogs |
| 04/10/2013 | EP2575787A1 Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation |
| 04/10/2013 | EP2575785A1 Oral dosage forms of bendamustine and therapeutic use thereof |
| 04/10/2013 | EP2575784A1 Oral dosage forms of bendamustine |
| 04/10/2013 | EP2575779A2 Use of diatomaceous earth in the pharmaceutical industry |
| 04/10/2013 | EP2575773A2 Synthetic nanocarrier combination vaccines |
| 04/10/2013 | EP2575768A1 Aqueous dispersion comprising galactolipids and method for production thereof |
| 04/10/2013 | EP2575767A1 Novel low molecular weight cationic lipids for oligonucleotide delivery |
| 04/10/2013 | EP2575764A2 Biodegradable lipids for the delivery of active agents |
| 04/10/2013 | EP2575763A2 Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer |
| 04/10/2013 | EP2575762A2 Removal of serine proteases by treatment with finely divided silicon dioxide |
| 04/10/2013 | EP2575761A1 Stable multi-dose compositions comprising an antibody and a preservative |
| 04/10/2013 | EP2575756A2 Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition |
| 04/10/2013 | EP2575745A1 Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that transcur through a deficit of maturation of the cornified envelope |
| 04/10/2013 | EP2575624A1 Ultrasound coupling liquid and container |
| 04/10/2013 | CN1856298B Tablet quickly disintegrating in oral cavity |
| 04/10/2013 | CN103038339A Deacetylation hydrolase of hyaluronic acid, hyaluronic acid deacetylated by same and derivative thereof |
| 04/10/2013 | CN103037904A 2-iminobiotin formulations and uses thereof |
| 04/10/2013 | CN103037903A Compositions and methods for treatment of autoimmune and other diseases |
| 04/10/2013 | CN103037898A Respiratory syncytial virus antigenic compositions and methods |
| 04/10/2013 | CN103037884A Pharmaceutical or neutraceutical formulation |
| 04/10/2013 | CN103037881A Novel formulations of active ingredient(s) of plant origin or synthetic analogues thereof or of extract(s) of plant origin containing same, and of lecithin |
| 04/10/2013 | CN103037864A Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease |
| 04/10/2013 | CN103037852A Oral dosage forms of bendamustine and therapeutic use thereof |
| 04/10/2013 | CN103037851A Oral dosage forms of bendamustine |
| 04/10/2013 | CN103037848A An injectable dosage form of flupirtine |
| 04/10/2013 | CN103037846A Combination therapy methods for treating proliferative diseases |
| 04/10/2013 | CN103037840A Lipid membrane structure with nuclear transferability |
| 04/10/2013 | CN103030801A Segmented degradable polymers and conjugates made therefrom |
| 04/10/2013 | CN103030738A Lawsone copolymer with antineoplastic activity and preparation method thereof |
| 04/10/2013 | CN103030731A Resin particle and applications of same |
| 04/10/2013 | CN103030696A Antibodies and immunoconjugates and uses therefor |
| 04/10/2013 | CN103030649A Novel ticarcillin disodium compound and composition of ticarcillin disodium compound with clavulanate potassium compound |
| 04/10/2013 | CN103030140A Oxidized graphene modified by hyaluronic acid and preparation method and application of medicinal composition of oxidized graphene modified by hyaluronic acid |
| 04/10/2013 | CN103028121A miR-21 compound of target microglial cell and preparation method and application of miR-21 compound |
| 04/10/2013 | CN103028118A Drug carriers, their synthesis, and methods of use thereof |
| 04/10/2013 | CN103028117A Method for preparing bacterial cellulose gel composite material |
| 04/10/2013 | CN103028116A Magnetic nano-composite microsphere based on cellulose base template and preparation method and use of magnetic nano-composite microsphere |
| 04/10/2013 | CN103028115A Programmed-drug-release azobenzene derivative carrier, and preparation method and application thereof |
| 04/10/2013 | CN103027981A Solid lipid nanoparticle of Gelan Xinning soft capsule for treating coronary heart disease and preparation method and application thereof |
| 04/10/2013 | CN103027902A Atractylone soft capsule and preparation method thereof |
| 04/10/2013 | CN103027901A Capsaicin chitosan microsphere-carried enteric coated tablet and preparation method thereof |
| 04/10/2013 | CN103027900A Repaglinide tablet and preparation method thereof |
| 04/10/2013 | CN103027899A Cephalosporin ester drug particle in non-gel state after meeting water, and preparation method and application of drug particle |
| 04/10/2013 | CN103027896A Sachet formulation for amine polymers |
| 04/10/2013 | CN103027895A Sugar-free cilnidipine dry-blend suspension and preparation method thereof |
| 04/10/2013 | CN103027894A Ceftazidime composition for injection and preparation method for ceftazidime composition |
| 04/10/2013 | CN103027893A Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 04/10/2013 | CN103027890A Ibuprofen medicine composition for injection |
| 04/10/2013 | CN102552177B Freeze-dried recombinant human brain natriuretic peptide (rhBNP) preparation and preparation method thereof |
| 04/10/2013 | CN102552137B Triptolide fat emulsion injection and preparation method thereof |
| 04/10/2013 | CN102525897B Injection solution of fasudil hydrochloride composition and preparation method thereof |
| 04/10/2013 | CN102429890B Medicinal composition containing cells and application thereof |
| 04/10/2013 | CN102416000B Chitosan quaternary ammonium salt macroporous microspheres for pulmonary inhalation and preparation method thereof |
| 04/10/2013 | CN102397554B Tumor-targeting double-drug carrying and delivery system and preparation method thereof |
| 04/10/2013 | CN102397258B Insulin carrying microsphere and preparation method thereof |
| 04/10/2013 | CN102309482B Clopidogrel hydrogensulfate composition and preparation method thereof |
| 04/10/2013 | CN102309440B Method for producing ganciclovir glucose injection |
| 04/10/2013 | CN102274222B High-bioavailability roflumilast medicinal composition and preparation method thereof |
| 04/10/2013 | CN102274196B 盐酸纳洛酮冻干粉针剂及其制备方法 Naloxone freeze-dried powder and its preparation method |
| 04/10/2013 | CN102240269B Preparation method of crystalline clopidogrel bisulfate tablets |
| 04/10/2013 | CN102228437B Co-immobilized TNF-a/IFN-g/DOX/FA/Fe3O4-OA magnetic targeted nanoparticle as well as preparation method and application thereof |
| 04/10/2013 | CN102204894B Iodized lecithin enteric capsule preparation and preparation method thereof |
| 04/10/2013 | CN102188420B Levetiracetam medicinal composition and preparation method thereof |
| 04/10/2013 | CN102178939B Muramidase hydrolase external sterile cream for treating skin ulcer and preparation method thereof |
| 04/10/2013 | CN102178658B Lappaconitine hydrobromide orally disintegrating tablets and preparation method thereof |
| 04/10/2013 | CN102166360B Ibuprofen intravenously administrable preparation and preparation method thereof |
| 04/10/2013 | CN102166190B Paclitaxel nano liposomes of dual targeting tumor and method for preparing paclitaxel nano liposomes |
| 04/10/2013 | CN102144963B Citicoline sodium glucose injecta and preparation process thereof |
| 04/10/2013 | CN102120016B Method for preparing Sichuan fritillary bulb and fructus momordicae cough relieving tablets |
| 04/10/2013 | CN102106821B Novel solid lipid nanoparticle medicament delivery system for protein-loaded medicaments |
| 04/10/2013 | CN102086266B Polypeptide-containing asymmetric hyperbranched amphoteric polyelectrolyte and preparation method thereof |